Huntington's Market Research Reports & Industry Analysis
Medications are available to help manage the symptoms of Huntington's disease, but treatments can't prevent the physical, mental and behavioral decline associated with the condition. After the onset of Huntington's disease, a person's functional abilities gradually worsen over time. The rate of disease progression and duration varies. The time from disease onset to death is often about 10 to 30 years. Juvenile onset usually results in death in fewer than 15 years.
The clinical depression associated with Huntington's disease may increase the risk of suicide. Some research suggests that the greater risk of suicide occurs before a diagnosis is made and in middle stages of the disease when a person has begun to lose independence. Eventually, a person with Huntington's disease requires help with all activities of daily living and care. Late in the disease, he or she will likely be confined to a bed and unable to speak. However, a person's understanding of surroundings and interactions remain intact for a long time.
Huntington's Industry Research & Market Reports
-
Neurology Clinical Trials Market Size, Share, and Outlook, 2025 Report- By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurology Clinical Trials segments across 22 countries ... Read More
-
Huntington’s Disease Treatment Market Size, Share, By Drug, Therapy Type, Route of Administration, Distribution Channel, and Region - Trends, Analysis, and Forecast till 2035
... chorea, cognitive decline, and psychiatric disturbances. It is a genetic condition that affects the cells in brain and it’s a progressive condition that gets worse over time. Target market is driven by high burden of ... Read More
-
Huntington`s Disease Therapeutics
... at a CAGR of 31.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 40.0% CAGR The Huntington`s Disease Therapeutics market in the U.S. ... Read More
-
Huntington's Disease Treatment Market Report by Type (Symptomatic Treatment, Disease-modifying Therapies), Drug Type (Approved Drugs, Off-label Drugs), Age (Below 50 Years, Above 50 Years), Distribution Channel (Drug Stores and Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
... End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033 The global Huntington's disease treatment market size reached USD 578.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,443 ... Read More
-
Innovation Insights: Anti-sense Oligonucleotides
... degradation, steric blocking, and modulation of splicing. ASOs have shown promise in treating various diseases, including genetic disorders, cancers, and inflammatory conditions. Notable examples include Sarepta therapeutics for spinal muscular atrophy and eteplirsen for Duchenne ... Read More
-
Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
Global Huntington’s Disease Treatment Market Forecast Report by Drug Type (Approved Drugs, Off-label Drugs) End user (Hospital Pharmacy, Drug Store & Retail Pharmacy, Online Pharmacy) Countries and Company Analysis, 2024-2032
... Global Huntington’s Disease Treatment Market is expected to grow beyond US$ 1,728.6 million in the year 2032, up from US$ 436.0 million in 2023, with a CAGR of 16.54 percent from 2024 to 2032. This ... Read More
-
2024 Global: Huntington'S Disease Treatment Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Neurodegenerative Disease Market Size, Trends, Analysis, and Outlook By Indication (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Others), By Drug (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Others), by Country, Segment, and Companies, 2024-2032
... Companies, 2024-2032 The global Neurodegenerative Disease market size is poised to register 7.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurodegenerative ... Read More
-
Brain Monitoring Market Size, Trends, Analysis, and Outlook By Device (Magnetic Resonance Imaging (MRI) Scanners, Computerized Tomography (CT) Scanners, Electroencephalograph (EEG) Devices, Positron Emission Tomography (PET) Scanners, Sleep Monitoring Devices, Cerebral Oximeters, Electromyography (EMG) Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Invasive Procedures, Non-invasive Procedures), By Modality (Fixed, Portable, Wearable), By Indication (Traumatic Brain Injury (TBI), Stroke, Dementia, Headache Disorders, Sleep Disorders, Parkinson’s Disease, Epilepsy, Huntington's Disease, Others), By End-User (Hospitals, Neurology Centers, Ambulatory Surgery Centers (ASCs), Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032
... Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Invasive Procedures, Non-invasive Procedures), By Modality (Fixed, ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Neurology Clinical Trials Market Size, Trends, Analysis, and Outlook By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), by Region, Country, Segment, and Companies, 2024-2030
... Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurology Clinical Trials market size is poised to register 5.35% growth from 2024 to 2030, ... Read More
-
Brain Monitoring Device Market Size, Trends, Analysis, and Outlook By Type (Magnetic Resonance Imaging (MRI) Scanners, Computerized Tomography (CT) Scanners, Electroencephalograph (EEG) Devices, Positron Emission Tomography (PET) Scanners, Sleep Monitoring Devices, Cerebral Oximeters, Electromyography (EMG) Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Wet Electrodes, Dry Electrodes, Needle Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Devices for Invasive Procedures, Devices for Non-invasive Procedures), By Modality (Fixed, Portable, Wearable), By Medical Condition (Traumatic Brain Injury (TBI), Stroke, Dementia, Headache Disorders, Sleep Disorders, Parkinson’s Disease, Epilepsy, Huntington's Disease, Other Medical Conditions), By End-User (Hospitals, Neurology Centers, Ambulatory Surgery Centers (ASCs) & Cli
... Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Wet Electrodes, Dry Electrodes, Needle Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Huntington's Disease Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
2024 Global Forecast for Huntington'S Disease Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Wireless Brain Sensors Market by Type of Product (Accessories, Electroencephalography (EEG) Devices, Intracranial Pressure (ICP) Monitors), Application (Dementia, Epilepsy, Huntington's Disease), End-User - Global Forecast 2024-2030
... USD 486.24 million in 2023 and expected to reach USD 545.88 million in 2024, at a CAGR 12.35% to reach USD 1,099.20 million by 2030. Global Wireless Brain Sensors Market FPNV Positioning Matrix The FPNV ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Global Huntington's Disease Market - 2023-2030
... period 2023-2030. Huntington's disease is an inherited disease that causes the degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on the functional abilities of humans and usually ... Read More
-
Huntington Disease Treatment Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Research. Huntington’s disease is an extraordinary, genetic situation that results in the revolutionary destruction of mind nerve cells. The useful capacities of a person are considerably impacted by using Huntington’s disease, which usually reasons mobility, ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Vocal Biomarkers Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Frequency, Amplitude, Error Rate, Vocal Rise/Fall Time, Phonation Time, Voice Tremor, Pitch); By Indications (Depression, Attention Deficit, Disruptive Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
... Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle ... Read More
-
Huntington Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Huntington Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
Research Assistance
